Kite Pharma Executive and Leadership Team

Neda Swisher, the Deputy Chief Operating Officer at Kite Pharma, drives operational excellence across the company's specialized cell therapy manufacturing and research functions. Swisher's leadership ensures the efficient scaling of Kite Pharma's unique approach to reengineering patient immune cells for cancer treatment. This role is critical in overseeing the complex logistical and production demands inherent in cell therapy manufacturing, supporting facilities in California, Maryland, and the Netherlands. Neda Swisher's operational strategies are designed to enhance the accessibility and delivery of these advanced treatments to eligible patients. By focusing on operational efficiency and quality control, Swisher directly contributes to the company's mission of treating and potentially curing cancer. The Deputy Chief Operating Officer's oversight is fundamental to maintaining the integrity and scalability of Kite Pharma's manufacturing processes, ensuring consistent product quality and timely patient access. Swisher's expertise is key to advancing the company's position in the competitive pharmaceutical landscape.

Leslie Millington, the Senior Director, Business Strategy & Operations Chief of Staff at Kite Pharma, directs strategic initiatives and operational execution. Millington ensures alignment between business objectives and the company's core mission of developing cell therapies for cancer. This leadership role involves optimizing internal processes and supporting the broader operational framework that enables Kite Pharma's unique approach to reengineering patient immune cells. Millington's focus on strategic planning and operational efficiency directly supports the company's commitment to making innovative treatments accessible. The scope of this position encompasses driving key projects and facilitating cross-functional collaboration to advance Kite Pharma's position in the pharmaceutical industry. Leslie Millington's contributions are vital to the seamless operation of the company's specialized manufacturing and research efforts, ensuring that therapeutic advancements translate into tangible patient benefits. The strategic oversight provided by Millington is critical for navigating the complexities of cell therapy development and deployment.

Rachel Hodge, the Senior Director, Business Strategy & Global Operations, To The Head of Commercial Chief of Staff at Kite Pharma, spearheads strategic business planning and global operational oversight within the commercial division. Hodge's responsibilities include enhancing the strategic direction of commercial operations and ensuring global functional alignment. This role is pivotal in translating Kite Pharma's innovative cell therapy treatments into accessible patient solutions across diverse markets. By focusing on global operations, Rachel Hodge supports the expansion and efficiency of the company's manufacturing and distribution networks, which are critical for delivering reengineered T cell therapies. The strategic insights provided by Hodge are essential for navigating international markets and ensuring compliance with varying regulatory landscapes. Kristen Draves' leadership in this capacity ensures that Kite Pharma's commercial strategies are robust and globally integrated, driving the company's mission forward. The operational frameworks developed under Hodge's guidance are fundamental to the company's ability to reach eligible patients worldwide.

Kristen Draves, the Director, Head of Business Strategy and Operations. Chief of Staff at Kite Pharma, directs critical business strategy initiatives and operational management. Draves ensures that the company's strategic objectives are effectively translated into actionable operational plans, supporting Kite Pharma's mission to develop and deliver innovative cell therapies for cancer. This position involves overseeing key operational functions that facilitate the reengineering of patient immune cells and the subsequent manufacturing of these specialized treatments. Kristen Draves' strategic focus enhances the efficiency and effectiveness of Kite Pharma's operations, contributing to the goal of making advanced cancer immunotherapies accessible. The role requires close collaboration with various departments to drive strategic alignment and operational improvements across the organization. Draves' leadership is instrumental in optimizing the company's operational framework, ensuring that Kite Pharma continues to advance its research and treatment capabilities. The strategic direction provided by Draves is vital for the company's ongoing success in the pharmaceutical sector.